These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. RUNX1 and CBFβ-SMMHC transactivate target genes together in abnormal myeloid progenitors for leukemia development. Zhen T; Cao Y; Ren G; Zhao L; Hyde RK; Lopez G; Feng D; Alemu L; Zhao K; Liu PP Blood; 2020 Nov; 136(21):2373-2385. PubMed ID: 32929473 [TBL] [Abstract][Full Text] [Related]
3. Runx1 is required for hematopoietic defects and leukemogenesis in Cbfb-MYH11 knock-in mice. Hyde RK; Zhao L; Alemu L; Liu PP Leukemia; 2015 Aug; 29(8):1771-8. PubMed ID: 25742748 [TBL] [Abstract][Full Text] [Related]
4. Cbfb/Runx1 repression-independent blockage of differentiation and accumulation of Csf2rb-expressing cells by Cbfb-MYH11. Hyde RK; Kamikubo Y; Anderson S; Kirby M; Alemu L; Zhao L; Liu PP Blood; 2010 Feb; 115(7):1433-43. PubMed ID: 20007544 [TBL] [Abstract][Full Text] [Related]
5. Gata2 deficiency delays leukemogenesis while contributing to aggressive leukemia phenotype in Cbfb-MYH11 knockin mice. Saida S; Zhen T; Kim E; Yu K; Lopez G; McReynolds LJ; Liu PP Leukemia; 2020 Mar; 34(3):759-770. PubMed ID: 31624376 [TBL] [Abstract][Full Text] [Related]
6. HDAC1 Is a Required Cofactor of CBFβ-SMMHC and a Potential Therapeutic Target in Inversion 16 Acute Myeloid Leukemia. Richter LE; Wang Y; Becker ME; Coburn RA; Williams JT; Amador C; Hyde RK Mol Cancer Res; 2019 Jun; 17(6):1241-1252. PubMed ID: 30814129 [TBL] [Abstract][Full Text] [Related]
7. Role of Cbfb in hematopoiesis and perturbations resulting from expression of the leukemogenic fusion gene Cbfb-MYH11. Kundu M; Chen A; Anderson S; Kirby M; Xu L; Castilla LH; Bodine D; Liu PP Blood; 2002 Oct; 100(7):2449-56. PubMed ID: 12239155 [TBL] [Abstract][Full Text] [Related]
8. Core-binding factor beta (CBFbeta), but not CBFbeta-smooth muscle myosin heavy chain, rescues definitive hematopoiesis in CBFbeta-deficient embryonic stem cells. Miller JD; Stacy T; Liu PP; Speck NA Blood; 2001 Apr; 97(8):2248-56. PubMed ID: 11290585 [TBL] [Abstract][Full Text] [Related]
9. Mechanism of leukemogenesis by the inv(16) chimeric gene CBFB/PEBP2B-MHY11. Shigesada K; van de Sluis B; Liu PP Oncogene; 2004 May; 23(24):4297-307. PubMed ID: 15156186 [TBL] [Abstract][Full Text] [Related]
10. miR-17 deregulates a core RUNX1-miRNA mechanism of CBF acute myeloid leukemia. Fischer J; Rossetti S; Datta A; Eng K; Beghini A; Sacchi N Mol Cancer; 2015 Jan; 14():7. PubMed ID: 25612891 [TBL] [Abstract][Full Text] [Related]
11. The leukemic protein core binding factor beta (CBFbeta)-smooth-muscle myosin heavy chain sequesters CBFalpha2 into cytoskeletal filaments and aggregates. Adya N; Stacy T; Speck NA; Liu PP Mol Cell Biol; 1998 Dec; 18(12):7432-43. PubMed ID: 9819429 [TBL] [Abstract][Full Text] [Related]
12. Function of the inv(16) fusion gene CBFB-MYH11. Kundu M; Liu PP Curr Opin Hematol; 2001 Jul; 8(4):201-5. PubMed ID: 11561156 [TBL] [Abstract][Full Text] [Related]
13. CBFB-MYH11 Fusion Sequesters RUNX1 in Cytoplasm to Prevent DNMT3A Recruitment to Target Genes in AML. Liu P; Liu JP; Sun SJ; Gao Y; Ai Y; Chen X; Sun Y; Zhou M; Liu Y; Xiong Y; Yuan HX Front Cell Dev Biol; 2021; 9():675424. PubMed ID: 34336831 [TBL] [Abstract][Full Text] [Related]
15. KIT with D816 mutations cooperates with CBFB-MYH11 for leukemogenesis in mice. Zhao L; Melenhorst JJ; Alemu L; Kirby M; Anderson S; Kench M; Hoogstraten-Miller S; Brinster L; Kamikubo Y; Gilliland DG; Liu PP Blood; 2012 Feb; 119(6):1511-21. PubMed ID: 22160378 [TBL] [Abstract][Full Text] [Related]
16. RUNX1 repression-independent mechanisms of leukemogenesis by fusion genes CBFB-MYH11 and AML1-ETO (RUNX1-RUNX1T1). Hyde RK; Liu PP J Cell Biochem; 2010 Aug; 110(5):1039-45. PubMed ID: 20589720 [TBL] [Abstract][Full Text] [Related]
17. Plag1 and Plagl2 are oncogenes that induce acute myeloid leukemia in cooperation with Cbfb-MYH11. Landrette SF; Kuo YH; Hensen K; Barjesteh van Waalwijk van Doorn-Khosrovani S; Perrat PN; Van de Ven WJ; Delwel R; Castilla LH Blood; 2005 Apr; 105(7):2900-7. PubMed ID: 15585652 [TBL] [Abstract][Full Text] [Related]
18. Proteogenomic analysis reveals cytoplasmic sequestration of RUNX1 by the acute myeloid leukemia-initiating CBFB::MYH11 oncofusion protein. Day RB; Hickman JA; Xu Z; Katerndahl CD; Ferraro F; Ramakrishnan SM; Erdmann-Gilmore P; Sprung RW; Mi Y; Townsend RR; Miller CA; Ley TJ J Clin Invest; 2023 Dec; 134(4):. PubMed ID: 38061017 [TBL] [Abstract][Full Text] [Related]
19. CBFB-MYH11/RUNX1 together with a compendium of hematopoietic regulators, chromatin modifiers and basal transcription factors occupies self-renewal genes in inv(16) acute myeloid leukemia. Mandoli A; Singh AA; Jansen PW; Wierenga AT; Riahi H; Franci G; Prange K; Saeed S; Vellenga E; Vermeulen M; Stunnenberg HG; Martens JH Leukemia; 2014 Apr; 28(4):770-8. PubMed ID: 24002588 [TBL] [Abstract][Full Text] [Related]
20. RT-PCR diagnosis of patients with acute nonlymphocytic leukemia and inv(16)(p13q22) and identification of new alternative splicing in CBFB-MYH11 transcripts. van der Reijden BA; Lombardo M; Dauwerse HG; Giles RH; Mühlematter D; Bellomo MJ; Wessels HW; Beverstock GC; van Ommen GJ; Hagemeijer A Blood; 1995 Jul; 86(1):277-82. PubMed ID: 7795233 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]